The Challenges of Treating Glucokinase MODY during Pregnancy: A Review of Maternal and Fetal Outcomes
Open Access
- 14 May 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (10) , 5980
Abstract
Background: The optimal treatment strategy for the follow-up and management of women with glucokinase maturity-onset diabetes of the young (GCK−MODY)during pregnancy remains unknown. Data regarding maternal and fetal outcomes are lacking. Aim: This paper summarizes the existing literature regarding the maternal and fetal outcomes of women with glucokinase MODY to guide future treatment strategy. Methods: A literature search was conducted in Pubmed, Embace, and Cochrane library with citation follow-up using the terms: glucokinase, MODY, diabetes, pregnancy, gestation, and outcomes. We searched for articles with known fetal mutational status. Relevant outcomes included: birthweight, large for gestational age (LGA), small for gestational age (SGA), macrosomia, cesarean delivery (CD), shoulder dystocia, congenital anomalies, miscarriages, preterm births, and long-term outcomes. Results: Fourteen relevant manuscripts were identified describing maternal and fetal outcomes. The percentage of LGA and macrosomia in 102 glucokinase -unaffected offspring (GCK−) was significantly higher than in the glucokinase -affected offspring (GCK+) (44% vs. 10%, p < 0.001 and 22% vs. 2%, p < 0.001, respectively). Among the 173 GCK(+) offspring, only 5% were SGA, which can be expected according to the normal distribution. We observed higher rates of CD and shoulder dystocia in the GCK(−) offspring. Conclusions: GCK(−) offspring have significantly higher birthweights and more birth complications. The optimal treatment strategy to guide management should take into consideration multiple variables other than fetal mutational status.Keywords
This publication has 24 references indexed in Scilit:
- The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the youngAmerican Journal of Obstetrics and Gynecology, 2015
- Identifying Glucokinase Monogenic Diabetes in a Multiethnic Gestational Diabetes Mellitus Cohort: New Pregnancy Screening Criteria and Utility of HbA1cDiabetes Care, 2015
- Monogenic glucokinase diabetes and pregnancy: a case studyWiener klinische Wochenschrift, 2015
- Clinical utility gene card for: Maturity-onset diabetes of the youngEuropean Journal of Human Genetics, 2014
- Antenatal Diagnosis of Fetal Genotype Determines if Maternal Hyperglycemia Due to a Glucokinase Mutation Requires TreatmentDiabetes Care, 2012
- Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutationDiabetic Medicine, 2009
- Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the youngDiabetologia, 2008
- Influence of maternal and fetal glucokinase mutations in gestational diabetesAmerican Journal of Obstetrics and Gynecology, 2001
- Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 familiesDiabetologia, 1997
- Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects.Journal of Clinical Investigation, 1996